首页> 外文期刊>Analytical and bioanalytical chemistry >Development and validation of a rapid LC-MS/MS method for the confirmatory analysis of the bound residues of eight nitrofuran drugs in meat using microwave reaction
【24h】

Development and validation of a rapid LC-MS/MS method for the confirmatory analysis of the bound residues of eight nitrofuran drugs in meat using microwave reaction

机译:快速LC-MS/MS方法的开发和验证,用于利用微波反应验证分析肉类中8种硝基呋喃药物的结合残基

获取原文
获取原文并翻译 | 示例

摘要

A rapid analytical method was developed and validated for the analysis of eight bound nitrofurans in animal tissue, shortening laboratory turnaround times from 4 to 2 days. The majority of methodologies for nitrofuran analysis focus on the detection of only four drugs (nitrofurantoin, furazolidone, furaltadone and nitrofurazone), and is time-consuming given the 16-h overnight derivatisation step and a double liquid-liquid extraction. In this study, the narrow scope of analysis was addressed by including further four important nitrofuran drugs (nifursol, nitrofuroxazide, nifuraldezone and nitrovin). Full chromatographic separation was achieved for the metabolites of all eight nitrofurans, using phenyl-hexyl column chemistry and a rigorous optimisation of the mobile phase additives and gradient profile. The conventional, lengthy sample preparation was substantially shortened by replacing the traditional overnight water bath derivatisation with a rapid 2-h microwave-assisted reaction, followed by a modified-QuEChERS (Quick, Easy, Cheap, Effective, Rugged and Safe) extraction. This confirmatory method was fully validated in accordance with the new 2021/808/EC legislation, and was shown to perform satisfactorily when applied to incurred tissues. The decision limit (CC alpha) for the eight analytes ranged between 0.013 and 0.200 mu g kg(-1), showing abundant sensitivity given that the current RPA for nitrofurans is 0.5 mu g kg(-1). This innovative method can play a major role in the surveillance of the illegal use of nitrofuran drugs.
机译:开发并验证了一种快速分析方法,用于分析动物组织中八种结合的硝基呋喃,将实验室周转时间从 4 天缩短到 2 天。大多数硝基呋喃分析方法仅侧重于检测四种药物(呋喃妥因、呋喃唑酮、呋喃他酮和呋喃酮),并且由于 16 小时的过夜衍生化步骤和双液-液萃取,因此非常耗时。在这项研究中,通过进一步纳入四种重要的硝基呋喃药物(硝呋索、硝基呋嗪、硝基呋喃肟和硝基素)来解决狭窄的分析范围。使用苯基-己基色谱柱填料并严格优化流动相添加剂和梯度曲线,对所有八种硝基呋喃的代谢物进行了完全色谱分离。通过用快速的 2 小时微波辅助反应取代传统的过夜水浴衍生化,然后进行改良的 QuEChERS(快速、简单、廉价、有效、坚固和安全)提取,大大缩短了传统的冗长样品制备时间。根据新的 2021/808/EC 法规,该确认方法已得到充分验证,并且在应用于发生组织时显示出令人满意的性能。八种分析物的决策限(CC alpha)范围在0.013至0.200 μ g kg(-1)之间,鉴于目前硝基呋喃的RPA为0.5 μ g kg(-1),显示出丰富的灵敏度。这种创新方法可以在监测非法使用硝基呋喃药物方面发挥重要作用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号